Input 2021.04.07 06:36 | Revision 2021.04.07 06:38
According to the BBC and others on the 6th (local time), health authorities in the UK stopped clinical trials in children while investigating the link between adult vaccination with the AstraZeneca vaccine and the occurrence of blood clots.
AstraZeneca has been conducting clinical trials to confirm the efficacy of about 300 children aged 6-17 years since last February.
In recent years, not only in Europe but also in the UK, there is a growing concern about the safety of the AstraZeneca vaccine in relation to blood clots. According to MHRA, there were 30 cases of blood clots after AstraZeneca vaccination last week. Of these, seven died. It is known that the British government is considering other vaccinations for people under the age of 30 in response to blood clots concerns.
On the same day, a high-ranking official from the European Medicines Agency (EMA) made a comment to the Italian media that the AstraZeneca vaccine was causally related to the specific thrombosis reported very rarely. However, EMA said it was cautious, saying it has not yet reached a conclusion.
British Prime Minister Boris Johnson also visited the AstraZeneca vaccine factory on the same day and said, “Follow the opinion of the MHRA. Their advice is to keep vaccinations” on a blood clot concern.
The World Health Organization (WHO) also adhered to the previous evaluation that the AstraZeneca vaccine has a greater benefit from vaccination than the risk. EMA also said the relationship between vaccines and blood clots is still under review and will be briefed as close to the 7th or 8th.